12

Cui Fang Bo

Oncology

About me

Specializing in the clinical and scientific research of anticancer drugs, especially targeted therapies. Serving as the principal investigator, leading a project funded by the National Natural Science Foundation of China. As the first author, published multiple academic papers, including 6 English-language papers indexed in SCI, with the highest impact factor being 6.49.

Proficient in diseases

Treatment with anticancer drugs, especially the use of targeted therapy for tumors.

voiceIcon

Voices

home-news-image
Written by Cui Fang Bo
Oncology
51sec home-news-image

Does oral cancer cause an increase in carcinoembryonic antigen?

When oral cancer occurs, there is a possibility that carcinoembryonic antigen (CEA) levels may be elevated. Among the current mainstream tumor markers, CEA is the most broadly applicable. Elevated levels of CEA can occur in a variety of tumors. However, an increase in CEA does not necessarily mean that oral cancer is present. Due to the relatively superficial location of the oral cavity, specific physical examinations of the mouth, or direct visualization of the inside of the mouth using auxiliary instruments, can be used to detect lesions associated with oral cancer. Once oral cancer is diagnosed, the primary treatments are surgery and radiotherapy. After surgery and radiotherapy, adjunctive chemotherapy can be used to improve treatment efficacy.

home-news-image
Written by Cui Fang Bo
Oncology
53sec home-news-image

Is thyroid cancer without lymph node metastasis considered early stage?

Thyroid cancer, if it has not metastasized to lymph nodes, generally falls under early-stage. Once thyroid cancer is diagnosed, surgical removal is the primary treatment choice. Postoperative treatments vary depending on the different pathological types of thyroid cancer. For the most common type, papillary carcinoma, if the surgery is radically curative, further treatment may not be necessary, and merely supplementing thyroid hormones suffices. In cases such as follicular carcinoma, undifferentiated carcinoma, or medullary carcinoma, even after surgically radical removal, postoperative treatment often requires further radiotherapy or treatment with Iodine-131, depending on the surgical pathology results. (The use of medications should be carried out under the guidance of a professional doctor.)